Magnus Aurivillius

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 4

Top Topics

Endoplasmic Reticulum Stress

Top Venues

International journal of chronic obstructive pulmonary disease

Therapeutic advances in respiratory disease

This page only lists publications with an associated author ORCID identifier.

Publications

Mona Bafadhel, Klaus Friedrich Rabe, Fernando J Martinez, Dave Singh, Patrick Darken, Martin Jenkins, Magnus Aurivillius, Mehul S Patel, Paul Dorinsky
Benefits of Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate on COPD Exacerbations, Lung Function, Symptoms, and Quality of Life Across Blood Eosinophil Ranges: A Post-Hoc Analysis of Data from ETHOS. International journal of chronic obstructive pulmonary disease 17 (2022)
Bärbel Huber, Claus Keller, Martin Jenkins, Abid Raza, Magnus Aurivillius
Effect of inhaled budesonide/formoterol fumarate dihydrate delivered via two different devices on lung function in patients with COPD and low peak inspiratory flow. Therapeutic advances in respiratory disease 16 (2022)
Mona Bafadhel, Klaus Friedrich Rabe, Fernando J Martinez, Dave Singh, Patrick Darken, Martin Jenkins, Magnus Aurivillius, Mehul S Patel, Paul Dorinsky
Benefits of Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate on COPD Exacerbations, Lung Function, Symptoms, and Quality of Life Across Blood Eosinophil Ranges: A Post-Hoc Analysis of Data from ETHOS. International journal of chronic obstructive pulmonary disease 17 (2022)
Mona Bafadhel, Klaus Friedrich Rabe, Fernando J Martinez, Dave Singh, Patrick Darken, Martin Jenkins, Magnus Aurivillius, Mehul S Patel, Paul Dorinsky
Benefits of Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate on COPD Exacerbations, Lung Function, Symptoms, and Quality of Life Across Blood Eosinophil Ranges: A Post-Hoc Analysis of Data from ETHOS. International journal of chronic obstructive pulmonary disease 17 (2022)